BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2018
View Archived Issues
Mutation links bipolar disorder to mitochondrial dysfunction
Read More
Teva discontinues two studies in phase III ENFORCE clinical development program of fremanezumab
Read More
Optimized benzothiazole amides presented as potential novel class of antimycobacterial agents
Read More
Blueprint Medicines reports updated data from ongoing phase I EXPLORER study of avapritinib
Read More
AGEN-2034 demonstrates early signs of clinical activity in cervical and ovarian tumors
Read More
URAT1 inhibitors identified at Atom Bioscience and Pharmaceutical
Read More
Integrative Research Laboratories Sweden describes modulators of neurotransmission
Read More
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7 agonists
Read More
CV6 Therapeutics identifies dUTPase inhibitors
Read More
Teijin Pharma divulges cyclin-dependent kinase CDK4/cyclin D3 and CDK6/cyclin D3 inhibitors
Read More
BridgeBio licenses LHON therapy from NeuroVive
Read More
hVIVO reports results from phase IIb field study of FLU-v
Read More
CytomX initiates first-in-human study of CX-2029 in patients with solid tumors or DLBCL
Read More
Phase I/II study of BioAtla's BA-3021 in advanced solid tumors begins
Read More
STF-1019 protects against experimental enterovirus 71 infection
Read More
Stemline Therapeutics presents data on SL-401 potentially useful in systemic sclerosis
Read More
Nirogacestat receives U.S. orphan drug designation for desmoid tumors
Read More
Celltrion resubmits aBLA for trastuzumab biosimilar CT-P6
Read More
Aminex initiates phase I study of AMXT-1501 dicaprate in advanced solid tumors
Read More
Evotec and Sanofi sign agreement in infectious diseases
Read More
Idorsia starts phase III REACT study with clazosentan
Read More
Phase Ib/IIa data for a small-molecule BET inhibitor PLX-51107
Read More